CompetitionThe company is seeing increased generic competition for Rynaxypyr in China, India, Eastern Europe and South America, pressuring both pricing and volumes.
Market ExpectationsThe 2026 EPS consensus is higher than the revised estimate, suggesting challenges in meeting market expectations.
Sales And Earnings ImpactA headwind from US tariffs on Canadian imports is expected to impact FMC's sales and earnings, with each 1% hit to US farm profits potentially cutting FMC sales by $3.8-5.8m.